Zai Lab Limited is a biopharmaceutical company that focuses on the development and commercialization of innovative therapies for oncology, autoimmune, infectious, and neurological diseases. Headquarte... Zai Lab Limited is a biopharmaceutical company that focuses on the development and commercialization of innovative therapies for oncology, autoimmune, infectious, and neurological diseases. Headquartered in Shanghai, China, Zai Lab aims to address significant unmet medical needs, emphasizing ground-breaking treatments with a potential to transform patient outcomes. The company's primary function is to enhance the availability of critical pharmaceuticals in both the Chinese and global markets, often operating through strategic partnerships and licensing agreements with leading global biotech entities. Notably, Zai Lab Limited has made significant strides in the oncology sector, bringing forth therapies that target various types of cancer. Its mission extends beyond product development, as the firm is also involved in conducting clinical trials and obtaining regulatory approvals efficiently. In the financial market, Zai Lab Limited is regarded as a dynamic player within the pharma and biotech industries, reflecting the increasing demand for advanced therapeutics in emerging markets and contributing to both medical innovation and economic growth.Show lessShow more

Disclosures ESG Data Financial Data

GHG Emissions Climate Targets EU Taxonomy Energy Waste Management

Data not available

No Climate Targets data disclosed by Zai Lab

We reviewed Zai Lab's website and available disclosure materials for the 2024 reporting period and did not identify any reported Climate Targets data.

If you would like us to review newly published materials or reassess the most recent disclosures, you can submit a data update request.

Would you like us to review Zai Lab's data?

Start your 30-day free trial to request a data review for Zai Lab.

Start Free Trial

Legal Center Contact Us